The benefit of integrating safety data from the FDA mandated registry with medwatch reports: A Southern Network on Adverse Reactions (SONAR) analysis based on the Tysabri Outreach Commitment to Health Registry (TOUCH).

Charles L. Bennett,Virginia Noxon,Paul R. Yarnold,A. Oliver Sartor,Brian Y. Chen

The benefit of integrating safety data from the FDA mandated registry with medwatch reports: A Southern Network on Adverse Reactions (SONAR) analysis based on the Tysabri Outreach Commitment to Health Registry (TOUCH).

2016

Charles L. Bennett
Virginia Noxon
Paul R. Yarnold
A. Oliver Sartor
Brian Y. Chen

e18237Background: Natalizumab is an effective therapy for multiple sclerosis. Its most notable toxicity is PML. The FDA mandated registry, TOUCH, focuses on PML cases. We identified an unusual case...

Keywords:

Emergency medicine
MedWatch
Physical therapy
Sonar
Outreach
Medicine
Natalizumab
Medical emergency
network on
unusual case

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations